Publications by authors named "Matthias Voth"

Claim this Profile
C
Cerebral neoplastic enhancing lesions: multicenter, randomized, crossover intraindividual comparison between gadobutrol (1.0M) and gadoterate meglumine (0.5M) at 0.1 mmol Gd/kg body weight in a clinical setting.
Nicoletta Anzalone, Tommaso Scarabino, Carlo Venturi, Concetto Cristaudo, Armando Tartaro, Matthias Voth

Eur J Radiol· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of gadobutrol, a new generation of contrast agents: experience from clinical trials and postmarketing surveillance.
Matthias Voth, Martin Rosenberg, Josy Breuer

Invest Radiol· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human brain tumor imaging with a protein-binding MR contrast agent: initial experience.
Marco Essig, Martin Rohrer, Frederik Giesel, Jochen Tüttenberg, Marc-André Weber, Matthias Voth

Eur Radiol· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peripheral magnetic resonance angiography with continuous table movement in combination with high spatial and temporal resolution time-resolved MRA With a total single dose (0.1 mmol/kg) of gadobutrol at 3.0 T.
Matthias Voth, Stefan Haneder, Kurt Huck, Alexandra Gutfleisch, Stefan O Schönberg

Invest Radiol· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biphasic blood pool contrast agent-enhanced whole-body MR angiography for treatment planning in patients with significant arterial stenosis.
Alexander Huppertz, Hannes Kroll, Christian Klessen, Matthias Taupitz, Ralph I Rückert, Matthias Voth

Invest Radiol· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Absolute quantification of regional renal blood flow in swine by dynamic contrast-enhanced magnetic resonance imaging using a blood pool contrast agent.
Lutz Lüdemann, Benno Nafz, Franz Elsner, Christian Grosse-Siestrup, Michael Meissler, Matthias Voth

Invest Radiol· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dicentric chromosomes and gamma-H2AX foci formation in lymphocytes of human blood samples exposed to a CT scanner: a direct comparison of dose response relationships.
Sven Golfier, Gregor Jost, Hubertus Pietsch, Philipp Lengsfeld, Friederike Eckardt-Schupp, Matthias Voth

Radiat Prot Dosimetry· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intravascular contrast agent T1 shortening: fast T1 relaxometry in a carotid volunteer study.
Michael Bock, Jessica Schulz, Stefan Ueltzhoeffer, Frederik Giesel, Matthias Voth

MAGMA· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-pass whole-body magnetic resonance angiography (MRA) using the blood-pool contrast medium gadofosveset trisodium: comparison to gadopentetate dimeglumine.
Christian Klessen, Patrick A Hein, Alexander Huppertz, Matthias Voth, Moritz Wagner

Invest Radiol· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment with granulocyte colony-stimulating factor for mobilization of bone marrow cells in patients with acute myocardial infarction.
Friedhelm Kuethe, Hans R Figulla, Michael Herzau, Matthias Voth, Michael Fritzenwanger

Am Heart J· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis